Drug Hunter

© Drug Hunter Inc. 2018-2022

Home > Sudapyridine (WX-081)

Sudapyridine (WX-081) Chemical Structure, oral ATP-synthase inhibitor - WuXi AppTec, Shanghai, CN

Sudapyridine (WX-081)

Recent Publication

oral ATP-synthase inhibitor

Ph. I candidate for pulmonary tuberculosis

toxicol. risk mitigation from prev. disclosed inhibitor

Bioorg. Med. Chem. Lett.

WuXi AppTec, Shanghai, CN

Context. Sudapyridine (WuXi AppTec) is an oral mycobacterial ATP synthase inhibitor being developed for tuberculosis (TB). Despite the significant success achieved with the discovery of antibiotic drugs in the…


 this content is exclusive to
Premium members

Upgrade to a Premium Drug Hunter membership to unlock the full content and start reading now.

Join Now

© Drug Hunter Inc. 2018-2022